BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med. 1997;337:473-479. [PMID: 9250851 DOI: 10.1056/nejm199708143370707] [Cited by in Crossref: 290] [Cited by in F6Publishing: 74] [Article Influence: 11.6] [Reference Citation Analysis]
Number Citing Articles
1 Yang N, Liu H, Jiang Y, Zheng J, Li DM, Ji C, Liu YY, Zuo PP. Lactulose enhances neuroplasticity to improve cognitive function in early hepatic encephalopathy. Neural Regen Res. 2015;10:1457-1462. [PMID: 26604907 DOI: 10.4103/1673-5374.165516] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
2 Bavdekar A, Bhave S, Pandit A. Nutrition management in chronic liver disease. Indian J Pediatr. 2002;69:427-431. [PMID: 12061678 DOI: 10.1007/bf02722636] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
3 Ramírez-polo A, Márquez-guillén E, González-aguirre AJ, Casanova-sánchez IE, Chávez-ruiz R, Carrillo-maravilla E, López-méndez E. Persistent hepatic encephalopathy secondary to portosystemic shunt occluded with Amplatzer device. Annals of Hepatology 2014;13:456-60. [DOI: 10.1016/s1665-2681(19)30854-3] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Hillebrand DJ. Spontaneous Bacterial Peritonitis. Curr Treat Options Gastroenterol. 2002;5:479-489. [PMID: 12408785 DOI: 10.1007/s11938-002-0036-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Balata S, Olde Damink SW, Ferguson K, Marshall I, Hayes PC, Deutz NE, Williams R, Wardlaw J, Jalan R. Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology 2003;37:931-9. [PMID: 12668989 DOI: 10.1053/jhep.2003.50156] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 4.1] [Reference Citation Analysis]
6 Demetriou AA. Brown RS Jr, Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch JS 2nd, Lerut J, Nyberg SL, Salizzoni M, Fagan EA, de Hemptinne B, Broelsch CE, Muraca M, Salmeron JM, Rabkin JM, Metselaar HJ, Pratt D, De La Mata M, McChesney LP, Everson GT, Lavin PT, Stevens AC, Pitkin Z, Solomon BA. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg. 2004;239:660-7; discussion 667-70. [PMID: 15082970 DOI: 10.1097/01.sla.0000124298.74199.e5] [Cited by in Crossref: 495] [Cited by in F6Publishing: 358] [Article Influence: 27.5] [Reference Citation Analysis]
7 Katayama K. Clinical significance of the latency period of abnormal ammonia metabolism in chronic liver disease: Proposal of a new concept. Hepatol Res 2021. [PMID: 34679199 DOI: 10.1111/hepr.13724] [Reference Citation Analysis]
8 Hadjihambi A, Jalan R. Hepatic encephalopathy: New treatments. Clin Liver Dis (Hoboken) 2015;5:109-11. [PMID: 31040962 DOI: 10.1002/cld.468] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
9 Solga SF, Diehl AM. Gut flora-based therapy in liver disease? The liver cares about the gut. Hepatology 2004;39:1197-200. [PMID: 15122746 DOI: 10.1002/hep.20220] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
10 Gerber T, Schomerus H. Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management. Drugs. 2000;60:1353-1370. [PMID: 11152016 DOI: 10.2165/00003495-200060060-00008] [Cited by in Crossref: 69] [Cited by in F6Publishing: 47] [Article Influence: 3.3] [Reference Citation Analysis]
11 Shen TC, Chehoud C, Ni J, Hsu E, Chen YY, Bailey A, Laughlin A, Bittinger K, Bushman FD, Wu GD. Dietary Regulation of the Gut Microbiota Engineered by a Minimal Defined Bacterial Consortium. PLoS One 2016;11:e0155620. [PMID: 27176607 DOI: 10.1371/journal.pone.0155620] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
12 Bhat M, Arendt BM, Bhat V, Renner EL, Humar A, Allard JP. Implication of the intestinal microbiome in complications of cirrhosis. World J Hepatol 2016; 8(27): 1128-1136 [PMID: 27721918 DOI: 10.4254/wjh.v8.i27.1128] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
13 Xie G, Wang X, Jiang R, Zhao A, Yan J, Zheng X, Huang F, Liu X, Panee J, Rajani C, Yao C, Yu H, Jia W, Sun B, Liu P. Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure. EBioMedicine. 2018;37:294-306. [PMID: 30344125 DOI: 10.1016/j.ebiom.2018.10.030] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
14 Huang K, Hu JH, Wang HF, He WP, Chen J, Duan XZ, Zhang AM, Liu XY. Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2011; 17(29): 3448-3452 [PMID: 21876637 DOI: 10.3748/wjg.v17.i29.3448] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
15 Levi I, Gurevich M, Perlman G, Magalashvili D, Menascu S, Bar N, Godneva A, Zahavi L, Chermon D, Kosower N, Wolf BC, Malka G, Lotan-Pompan M, Weinberger A, Yirmiya E, Rothschild D, Leviatan S, Tsur A, Didkin M, Dreyer S, Eizikovitz H, Titngi Y, Mayost S, Sonis P, Dolev M, Stern Y, Achiron A, Segal E. Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysis. Cell Rep Med 2021;2:100246. [PMID: 33948576 DOI: 10.1016/j.xcrm.2021.100246] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Stange J. Extracorporeal liver support. Organogenesis 2011;7:64-73. [PMID: 21343699 DOI: 10.4161/org.7.1.14069] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
17 Nath A, Haktanirlar G, Varga Á, Molnár MA, Albert K, Galambos I, Koris A, Vatai G. Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System. Medicina (Kaunas) 2018;54:E18. [PMID: 30344249 DOI: 10.3390/medicina54020018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
18 Roy J, Kang M, Stern B, Riley T, Schreibman I. Lactulose-induced pneumatosis intestinalis following colonoscopy: a case report. Clin J Gastroenterol 2021;14:1152-6. [PMID: 33772734 DOI: 10.1007/s12328-021-01392-9] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Greenberg DB. Preventing Delirium at the End of Life: Lessons From Recent Research. Prim Care Companion J Clin Psychiatry 2003;5:62-7. [PMID: 15156232 DOI: 10.4088/pcc.v05n0201] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
20 Griffin JWD, Bradshaw PC. Effects of a high protein diet and liver disease in an in silico model of human ammonia metabolism. Theor Biol Med Model 2019;16:11. [PMID: 31366360 DOI: 10.1186/s12976-019-0109-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Pineda JA, García-garcía JA. Reply:. Hepatology 2005;42:497-497. [DOI: 10.1002/hep.20809] [Reference Citation Analysis]
22 Mahmoud AM, Alqahtani S, Othman SI, Germoush MO, Hussein OE, Al-Basher G, Khim JS, Al-Qaraawi MA, Al-Harbi HM, Fadel A, Allam AA. Commiphora molmol Modulates Glutamate-Nitric Oxide-cGMP and Nrf2/ARE/HO-1 Pathways and Attenuates Oxidative Stress and Hematological Alterations in Hyperammonemic Rats. Oxid Med Cell Longev 2017;2017:7369671. [PMID: 28744340 DOI: 10.1155/2017/7369671] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
23 Gruenbaum BF, Boyko M, Delgado B, Douvdevany A, Gruenbaum SE, Melamed I, Gideon M, Cesnulis E, Shapira Y, Zlotnik A. Cell-free DNA as a potential marker to predict carbon tetrachloride-induced acute liver injury in rats. Hepatol Int 2013;7:721-7. [PMID: 26201806 DOI: 10.1007/s12072-012-9414-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
24 Arora V, Vijayaraghavan R, Maiwall R, Sahney A, Thomas SS, Ali R, Jain P, Kumar G, Sarin SK. Paracentesis-Induced Circulatory Dysfunction With Modest-Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute-on-Chronic Liver Failure. Hepatology 2020;72:1043-55. [PMID: 31849085 DOI: 10.1002/hep.31071] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
25 Kida Y, Ueda H, Tanaka H, Ichinose M. Estimation of protein intake using urinary urea nitrogen in patients with early-stage liver cirrhosis. Hepatol Int 2007;1:382-6. [PMID: 19669333 DOI: 10.1007/s12072-007-9019-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
26 Gasteiger L, Eschertzhuber S, Tiefenthaler W. Perioperative management of liver surgery-review on pathophysiology of liver disease and liver failure. Eur Surg 2018;50:81-6. [PMID: 29875796 DOI: 10.1007/s10353-018-0522-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
27 Toris GT, Bikis CN, Tsourouflis GS, Theocharis SE. Hepatic encephalopathy: an updated approach from pathogenesis to treatment. Med Sci Monit 2011;17:RA53-63. [PMID: 21278704 DOI: 10.12659/msm.881387] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
28 Perumalswami PV, Schiano TD. The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci 2011;56:1266-81. [PMID: 21416246 DOI: 10.1007/s10620-011-1619-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
29 Farmer DG, Anselmo DM, Ghobrial RM, Yersiz H, McDiarmid SV, Cao C, Weaver M, Figueroa J, Khan K, Vargas J, Saab S, Han S, Durazo F, Goldstein L, Holt C, Busuttil RW. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg. 2003;237:666-75; discussion 675. [PMID: 12724633 DOI: 10.1097/01.sla.0000064365.54197.9e] [Cited by in Crossref: 103] [Cited by in F6Publishing: 21] [Article Influence: 5.4] [Reference Citation Analysis]
30 Al Sibae MR, McGuire BM. Current trends in the treatment of hepatic encephalopathy. Ther Clin Risk Manag. 2009;5:617-626. [PMID: 19707277 DOI: 10.2147/tcrm.s4443] [Cited by in Crossref: 8] [Cited by in F6Publishing: 19] [Article Influence: 0.6] [Reference Citation Analysis]
31 Pérez-fidalgo J, Chirivella González I, Günthner S, Cervera Miguel J, March Villalba J, Cervantes Ruipérez A. La encefalopatía hiperamonémica, una posible complicación por derivación urinaria tras cistectomía radical. Revisión de la literatura a proposito de un caso. Actas Urológicas Españolas 2007;31:394-9. [DOI: 10.1016/s0210-4806(07)73654-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Eltawil KM, Laryea M, Peltekian K, Molinari M. Rifaximin vs conventional oral therapy for hepatic encephalopathy: A meta-analysis. World J Gastroenterol 2012; 18(8): 767-777 [PMID: 22371636 DOI: 10.3748/wjg.v18.i8.767] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
33 Shaw J, Tate V, Hanson J, Bajaj JS. What diet should I recommend my patient with Hepatic Encephalopathy? Curr Hepatol Rep 2020;19:13-22. [PMID: 33457180 DOI: 10.1007/s11901-020-00510-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
34 Hassanein TI, Tofteng F, Brown RS Jr, McGuire B, Lynch P, Mehta R, Larsen FS, Gornbein J, Stange J, Blei AT. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007;46:1853-62. [PMID: 17975845 DOI: 10.1002/hep.21930] [Cited by in Crossref: 285] [Cited by in F6Publishing: 222] [Article Influence: 19.0] [Reference Citation Analysis]
35 Nicaise C, Prozzi D, Viaene E, Moreno C, Gustot T, Quertinmont E, Demetter P, Suain V, Goffin P, Devière J, Hols P. Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents. Hepatology 2008;48:1184-92. [PMID: 18697211 DOI: 10.1002/hep.22445] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
36 Merola J, Chaudhary N, Qian M, Jow A, Barboza K, Charles H, Teperman L, Sigal S. Hyponatremia: A Risk Factor for Early Overt Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation. J Clin Med 2014;3:359-72. [PMID: 26237379 DOI: 10.3390/jcm3020359] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
37 Bergheim I, McClain CJ, Arteel GE. Treatment of alcoholic liver disease. Dig Dis 2005;23:275-84. [PMID: 16508292 DOI: 10.1159/000090175] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
38 Marino RT, Sidlak AM. Hyperammonemia in acetaminophen toxicity. Clin Toxicol (Phila) 2022;60:126-30. [PMID: 34080505 DOI: 10.1080/15563650.2021.1933512] [Reference Citation Analysis]
39 Goodman RA, Riley TR 3rd. Lactulose-induced pneumatosis intestinalis and pneumoperitoneum. Dig Dis Sci 2001;46:2549-53. [PMID: 11713968 DOI: 10.1023/a:1012308911096] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
40 Patel NH. Portal hypertension. Semin Roentgenol 2002;37:293-302. [PMID: 12455127 DOI: 10.1016/s0037-198x(02)80006-2] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
41 Kim JW, Gwon DI, Ko G, Yoon H, Shin JH, Kim JH, Ko HK, Sung K. Stent Dysfunction After Transjugular Intrahepatic Portosystemic Shunt: A 14-Year Experience from a Single Tertiary Medical Center. Iran J Radiol 2017;15. [DOI: 10.5812/iranjradiol.15579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
42 Stojadinovic A, Allen PJ, Shriver CD. Metastatic carcinoid tumour presenting as hepatic encephalopathy. HPB (Oxford) 2002;4:47-50. [PMID: 18333153 DOI: 10.1080/136518202753598744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Sama C, Morselli-Labate AM, Pianta P, Lambertini L, Berardi S, Martini G. Clinical effects of rifaximin in patientswith hepatic encephalopathy intolerant or nonresponsive to previous lactulose treatment: An open-label, pilot study. Curr Ther Res Clin Exp 2004;65:413-22. [PMID: 24672094 DOI: 10.1016/j.curtheres.2004.10.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
44 Mardini H, Record C. Pathogenesis of hepatic encephalopathy: lessons from nitrogen challenges in man. Metab Brain Dis. 2013;28:201-207. [PMID: 23180318 DOI: 10.1007/s11011-012-9362-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
45 Sharma P, Sharma BC. Disaccharides in the treatment of hepatic encephalopathy. Metab Brain Dis 2013;28:313-20. [PMID: 23456517 DOI: 10.1007/s11011-013-9392-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
46 Merli M, Riggio O. Dietary and nutritional indications in hepatic encephalopathy. Metab Brain Dis 2009;24:211-21. [PMID: 19052853 DOI: 10.1007/s11011-008-9127-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
47 Alexander B, Aslam M, Nobin A, Benjamin IS. Differentiation between the effects of unprocessed portal blood and reduced liver function on brain indole amine metabolism in the portacaval shunted rat. Metab Brain Dis 1998;13:137-46. [PMID: 9699921 DOI: 10.1023/a:1020661230502] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Sigal SH, Stanca CM, Kontorinis N, Bodian C, Ryan E. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol 2006;101:1490-6. [PMID: 16863551 DOI: 10.1111/j.1572-0241.2006.00649.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 3.3] [Reference Citation Analysis]
49 Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC, Arora A, Acharya SK, Benjamin J, Chawla YK, Dadhich S, Duseja A, Eapan CE, Goel A, Kalra N, Kapoor D, Kumar A, Madan K, Nagral A, Pandey G, Rao PN, Saigal S, Saraf N, Saraswat VA, Saraya A, Sarin SK, Sharma P, Shalimar, Shukla A, Sidhu SS, Singh N, Singh SP, Srivastava A, Wadhawan M. Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver. J Clin Exp Hepatol 2021;11:97-143. [PMID: 33679050 DOI: 10.1016/j.jceh.2020.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Arora V, Maiwall R, Rajan V, Jindal A, Muralikrishna Shasthry S, Kumar G, Jain P, Sarin SK. Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure. Hepatology 2020;71:600-10. [PMID: 30076614 DOI: 10.1002/hep.30208] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 31.0] [Reference Citation Analysis]
51 Dziodzio T, Öllinger R, Schöning W, Rothkäppel A, Nikolov R, Juraszek A, Ritschl PV, Stockmann M, Pratschke J, Jara M. Validation of a new prognostic model to predict short and medium-term survival in patients with liver cirrhosis. BMC Gastroenterol 2020;20:265. [PMID: 32787947 DOI: 10.1186/s12876-020-01407-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Grover VP, Tognarelli JM, Massie N, Crossey MM, Cook NA, Taylor-Robinson SD. The why and wherefore of hepatic encephalopathy. Int J Gen Med 2015;8:381-90. [PMID: 26719720 DOI: 10.2147/IJGM.S86854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
53 Soria LR, Allegri G, Melck D, Pastore N, Annunziata P, Paris D, Polishchuk E, Nusco E, Thöny B, Motta A, Häberle J, Ballabio A, Brunetti-Pierri N. Enhancement of hepatic autophagy increases ureagenesis and protects against hyperammonemia. Proc Natl Acad Sci U S A 2018;115:391-6. [PMID: 29279371 DOI: 10.1073/pnas.1714670115] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
54 Phongsamran PV, Kim JW, Cupo Abbott J, Rosenblatt A. Pharmacotherapy for Hepatic Encephalopathy: . Drugs 2010;70:1131-48. [DOI: 10.2165/10898630-000000000-00000] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
55 Kako Y, Yamakado K, Jomoto W, Nasada T, Asada K, Takaki H, Kobayashi K, Daimon T, Hirota S. Changes in liver perfusion and function before and after percutaneous occlusion of spontaneous portosystemic shunt. Jpn J Radiol 2017;35:366-72. [PMID: 28501975 DOI: 10.1007/s11604-017-0647-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
56 Seymour CA, Whelan K. Dietary management of hepatic encephalopathy. BMJ 1999;318:1364-5. [PMID: 10334724 DOI: 10.1136/bmj.318.7195.1364] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
57 Kromas ML, Mousa OY, John S. Hyperammonemia-induced encephalopathy: A rare devastating complication of bariatric surgery. World J Hepatol 2015; 7(7): 1007-1011 [PMID: 25954483 DOI: 10.4254/wjh.v7.i7.1007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
58 Sharma P, Sharma BC. Management of overt hepatic encephalopathy. J Clin Exp Hepatol 2015;5:S82-7. [PMID: 26041964 DOI: 10.1016/j.jceh.2014.04.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
59 Fox R, Stenning K, Slee A, Macnaughtan J, Davies N. Sarcopenia in liver cirrhosis: Prevalence, pathophysiology and therapeutic strategies. Analytical Biochemistry 2022. [DOI: 10.1016/j.ab.2022.114581] [Reference Citation Analysis]
60 Kajiwara K, Okuno M, Kobayashi T, Honma N, Maki T, Kato M, Ohnishi H, Muto Y, Moriwaki H. Oral supplementation with branched-chain amino acids improves survival rate of rats with carbon tetrachloride-induced liver cirrhosis. Dig Dis Sci 1998;43:1572-9. [PMID: 9690397 DOI: 10.1023/a:1018831302578] [Cited by in Crossref: 34] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
61 Bian T, Zhang X, He G, Duan Z, Dong C, Li X, Guo N. Citric acid-loaded W 1 /O/W 2 multiple emulsions efficiently remove colonic ammonia both in vitro and in vivo. Journal of Dispersion Science and Technology 2017;38:1-7. [DOI: 10.1080/01932691.2015.1038750] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
62 Shafey GM, Rashed ER, Zaki HF, Attia AS, El-Ghazaly MA. Molecular mechanisms involved in the effects of morin in experimental hepatic encephalopathy. Biofactors 2022. [PMID: 35332953 DOI: 10.1002/biof.1838] [Reference Citation Analysis]
63 Goralczyk AD, Meier V, Ramadori G, Obed A, Lorf T. Acute paranoid psychosis as sole clinical presentation of hepatic artery thrombosis after living donor liver transplantation. BMC Surg 2010;10:7. [PMID: 20175918 DOI: 10.1186/1471-2482-10-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Caraceni P, Vargas V, Solà E, Alessandria C, de Wit K, Trebicka J, Angeli P, Mookerjee RP, Durand F, Pose E, Krag A, Bajaj JS, Beuers U, Ginès P; Liverhope Consortium. The Use of Rifaximin in Patients With Cirrhosis. Hepatology 2021;74:1660-73. [PMID: 33421158 DOI: 10.1002/hep.31708] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 20.0] [Reference Citation Analysis]
65 Adrover R, Cocozzella D, Ridruejo E, García A, Rome J, Podestá JJ. Breath-ammonia testing of healthy subjects and patients with cirrhosis. Dig Dis Sci. 2012;57:189-195. [PMID: 21842240 DOI: 10.1007/s10620-011-1858-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
66 Leevy CB, Phillips JA. Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy. Dig Dis Sci. 2007;52:737-741. [PMID: 17245628 DOI: 10.1007/s10620-006-9442-4] [Cited by in Crossref: 111] [Cited by in F6Publishing: 92] [Article Influence: 7.4] [Reference Citation Analysis]
67 Jara M, Dziodzio T, Malinowski M, Lüttgert K, Nikolov R, Ritschl PV, Öllinger R, Pratschke J, Stockmann M. Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis. Dig Dis Sci 2019;64:576-84. [PMID: 30406480 DOI: 10.1007/s10620-018-5360-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Zang H, Liu F, Liu H, You S, Zhu B, Wan Z, Xin S. Incidence, risk factors and outcomes of acute kidney injury (AKI) in patients with acute-on-chronic liver failure (ACLF) of underlying cirrhosis. Hepatol Int 2016;10:807-18. [DOI: 10.1007/s12072-016-9756-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
69 Liu F, Zou Z, Shen L, Wu W, Luo J, Lankford S, Yang Y, Huang H, You S, Zhu B, Li J, Mu J, Zhang Y, Xin S. A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure. Sci Rep 2020;10:20176. [PMID: 33214662 DOI: 10.1038/s41598-020-77235-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Gómez-Hurtado I, Such J, Sanz Y, Francés R. Gut microbiota-related complications in cirrhosis. World J Gastroenterol 2014; 20(42): 15624-15631 [PMID: 25400446 DOI: 10.3748/wjg.v20.i42.15624] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
71 Scotiniotis IA, Lucey MR, Metz DC. Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients. Dig Dis Sci. 2001;46:2744-2751. [PMID: 11768268 DOI: 10.1023/a:1012787731821] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
72 Kang Y, Kim EJ, Kim SG, Kim YS, Lee JM, Kim BS. Plug-Assisted Retrograde Transvenous Obliteration of Spontaneous Splenorenal Shunt for Refractory Hepatic Encephalopathy: Case Series. Soonchunhyang Med Sci 2016;22:23-6. [DOI: 10.15746/sms.16.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
73 Moser MJ, Gong Y, Zhang MN, Lipschitz J, Cohen A, Minuk GY. The effects of colectomy on immediate-early proto-oncogene expression and hepatic regeneration in the rat. Dig Dis Sci 2006;51:1179-82. [PMID: 16944006 DOI: 10.1007/s10620-006-8029-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
74 Radovich PA. Use of transjugular intrahepatic portosystemic shunt in liver disease. Journal of Vascular Nursing 2000;18:83-7. [DOI: 10.1067/mvn.2000.107688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
75 Alexander B, Li X, Benjamin IS, Segal MB, Sherwood R, Preston JE. A quantitative evaluation of the permeability of the blood brain barrier of portacaval shunted rats. Metab Brain Dis. 2000;15:93-103. [PMID: 11092576 DOI: 10.1007/bf02679976] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
76 Sheng JQ, Hu PJ, Liu X, Huang TS, Chen YH. Predictive Analytics for Care and Management of Patients With Acute Diseases: Deep Learning-Based Method to Predict Crucial Complication Phenotypes. J Med Internet Res 2021;23:e18372. [PMID: 33576744 DOI: 10.2196/18372] [Reference Citation Analysis]
77 Lo Re V 3rd, Carbonari DM, Forde KA, Goldberg D, Lewis JD, Haynes K, Leidl KB, Reddy RK, Roy J, Sha D, Marks AR, Schneider JL, Strom BL, Corley DA. Validity of diagnostic codes and laboratory tests of liver dysfunction to identify acute liver failure events. Pharmacoepidemiol Drug Saf 2015;24:676-83. [PMID: 25866286 DOI: 10.1002/pds.3774] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
78 Kircheis G, Wettstein M, Dahl Sv, Häussinger D. Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy. Metab Brain Dis 2002;17:453-62. [PMID: 12602521 DOI: 10.1023/a:1021934607762] [Cited by in Crossref: 56] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
79 Nguyen DL, Morgan T. Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view. Hepatol Int 2014;8:447-51. [PMID: 25525477 DOI: 10.1007/s12072-013-9497-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
80 Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-71. [PMID: 10733541 DOI: 10.1053/he.2000.5852] [Cited by in Crossref: 1860] [Cited by in F6Publishing: 1623] [Article Influence: 84.5] [Reference Citation Analysis]
81 El-Latif El-Ghazaly MA, Rashed ER, Shafey GM, Zaki HF, Attia AS. Amelioration of thioacetamide-induced hepatic encephalopathy in rats by low-dose gamma irradiation. Environ Sci Pollut Res Int 2020;27:334-43. [PMID: 31786756 DOI: 10.1007/s11356-019-06934-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
82 Dbouk N, McGuire BM. Hepatic encephalopathy: a review of its pathophysiology and treatment. Curr Treat Options Gastroenterol 2006;9:464-74. [PMID: 17081480 DOI: 10.1007/s11938-006-0003-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
83 Li C, Su HB, Li H, Li X, Wang HM, Song Q, Hu JH. Severe acute liver injury in patients with exertional heat stroke associated with poor short-term prognosis. World J Emerg Med 2022;13:124-9. [PMID: 35237366 DOI: 10.5847/wjem.j.1920-8642.2022.047] [Reference Citation Analysis]
84 Lo Re V, Lim JK, Goetz MB, Tate J, Bathulapalli H, Klein MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Gibert CL. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf. 2011;20:689-699. [PMID: 21626605 DOI: 10.1002/pds.2148] [Cited by in Crossref: 95] [Cited by in F6Publishing: 94] [Article Influence: 8.6] [Reference Citation Analysis]
85 Xiong J, Zhang M, Guo X, Pu L, Xiong H, Xiang P, Liu J, Li A. Acute kidney injury in critically ill cirrhotic patients with spontaneous bacterial peritonitis: a comparison of KDIGO and ICA criteria. Arch Med Sci 2020;16:569-76. [PMID: 32399104 DOI: 10.5114/aoms.2019.85148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
86 Li C, Su HB, Liu XY, Hu JH. Clinical characteristics and 28-d outcomes of bacterial infections in patients with hepatitis B virus-related acute-on-chronic liver failure. World J Clin Cases 2020; 8(6): 1042-1055 [PMID: 32258075 DOI: 10.12998/wjcc.v8.i6.1042] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
87 Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004;39:1441-9. [PMID: 15122774 DOI: 10.1002/hep.20194] [Cited by in Crossref: 423] [Cited by in F6Publishing: 380] [Article Influence: 23.5] [Reference Citation Analysis]
88 Paik YH, Lee KS, Han KH, Song KH, Kim MH, Moon BS, Ahn SH, Lee SJ, Park HJ, Lee DK, Chon CY, Lee SI, Moon YM. Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study. Yonsei Med J. 2005;46:399-407. [PMID: 15988813 DOI: 10.3349/ymj.2005.46.3.399] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 4.7] [Reference Citation Analysis]
89 Ytrebø LM, Kristiansen RG, Maehre H, Fuskevåg OM, Kalstad T, Revhaug A, Cobos MJ, Jalan R, Rose CF. L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure. Hepatology 2009;50:165-74. [PMID: 19554542 DOI: 10.1002/hep.22917] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 5.4] [Reference Citation Analysis]
90 Bhagavan N. Protein and Amino Acid Metabolism. Medical Biochemistry. Elsevier; 2002. pp. 331-63. [DOI: 10.1016/b978-012095440-7/50019-6] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
91 Teperman LW. Impact of pretransplant hepatic encephalopathy on liver posttransplantation outcomes. Int J Hepatol 2013;2013:952828. [PMID: 24324895 DOI: 10.1155/2013/952828] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
92 Minuk GY, Hawkins K, Kaita KD, Wong S, Renner E, Minuk L, Uhanova J. Daily ciprofloxacin treatment for patients with advanced liver disease awaiting liver transplantation reduces hospitalizations. Dig Dis Sci 2011;56:1235-41. [PMID: 21057977 DOI: 10.1007/s10620-010-1456-2] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
93 Shen TC, Albenberg L, Bittinger K, Chehoud C, Chen YY, Judge CA, Chau L, Ni J, Sheng M, Lin A. Engineering the gut microbiota to treat hyperammonemia. J Clin Invest. 2015;125:2841-2850. [PMID: 26098218 DOI: 10.1172/jci79214] [Cited by in Crossref: 103] [Cited by in F6Publishing: 59] [Article Influence: 14.7] [Reference Citation Analysis]
94 Frank D, Savir S, Gruenbaum BF, Melamed I, Grinshpun J, Kuts R, Knyazer B, Zlotnik A, Vinokur M, Boyko M. Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube. J Vis Exp 2020. [PMID: 32420997 DOI: 10.3791/60695] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Panatto JP, Jeremias IC, Ferreira GK, Ramos AC, Rochi N, Gonçalves CL, Daufenbach JF, Jeremias GC, Carvalho-Silva M, Rezin GT, Scaini G, Streck EL. Inhibition of mitochondrial respiratory chain in the brain of rats after hepatic failure induced by acetaminophen. Mol Cell Biochem 2011;350:149-54. [PMID: 21203802 DOI: 10.1007/s11010-010-0689-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
96 Sharma P, Sharma BC. Profile of hepatic encephalopathy in children with cirrhosis and response to lactulose. Saudi J Gastroenterol. 2011;17:138-141. [PMID: 21372353 DOI: 10.4103/1319-3767.77246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
97 Kajiwara K, Okuno M, Kobayashi T, Honma N, Maki T, Kato M, Ohnishi H, Muto Y, Moriwaki H. Oral supplementation with branched-chain amino acids improves survival rate of rats with carbon tetrachloride-induced liver cirrhosis. Dig Dis Sci. 1998;43:1572-1579. [PMID: 9690397 DOI: 10.1023/a: 1018831302578] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Xia L, Chen WX, Yu YM, Lv NH, Hu Y. Efficacy of lactulose in prophylaxis of hepatic encephalopathy after acute gastrointestinal bleeding: A meta-analysis. Shijie Huaren Xiaohua Zazhi 2016; 24(4): 594-600 [DOI: 10.11569/wcjd.v24.i4.594] [Reference Citation Analysis]
99 Dalal R, McGee RG, Riordan SM, Webster AC. Probiotics for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017;2:CD008716. [PMID: 28230908 DOI: 10.1002/14651858.cd008716.pub3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
100 Sajja KC, Dolmatch BL, Rockey DC. Long-term follow-up of TIPS created with expanded poly-tetrafluoroethylene covered stents. Dig Dis Sci. 2013;58:2100-2106. [PMID: 23381105 DOI: 10.1007/s10620-013-2578-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]